|
May 2006
ISPOR
e-BULLETIN provides updates of recent ISPOR activities and events. For detailed
information on ISPOR activities, members are encouraged to go to
www.ispor.org.
Please share these new ISPOR activities with your colleagues.
NEW THIS MONTH
**NEW**
ISPOR 11th Annual European International Meeting-UPDATES
**UPDATE**
Evidence-Based Medicine Symposium
**NEW**
Student Activities at 11th Annual International Meeting
**NEW**
ISPOR 9th Annual European Congress - UPDATES
**NEW**
Value in Health Vol. 9 No. 3 (May/June 2006)
**NEW**
ISPOR CONNECTIONS Volume 12, Issue 2 (March/April 2006)
**NEW**
ISPOR Special Interest Group (SIG) - UPDATES
**NEW**
Over 50
New Positions at the ISPOR Website
IMPORTANT DATES TO REMEMBER
Ø
20-24
May 2006 - ISPOR 11th Annual International Meeting, Marriott
Philadelphia, Philadelphia, PA, USA
Ø
19
June 2006 - Abstract submission deadline ISPOR 9th Annual European
Congress, 28-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark
Ø
26
September 2006 - Early registration deadline ISPOR 9th Annual European
Congress, 28-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark
Ø
28-31
October 2006 - ISPOR 9th Annual European Congress, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark
ISPOR ONGOING ACTIVITIES
1.
Publications
2.
Meetings and Congresses
3.
Educational Activities
4.
Student News
5.
ISPOR Special Interest Groups
6.
Committee and Task Force Activities
7.
Asia Consortium and Local
Chapter News
8.
Employment in Pharmacoeconomics and Outcomes Research
9.
Membership
1. PUBLICATIONS
Top
VALUE IN HEALTH
**NEW**
Value in Health Volume 9, Issue 3, May/June 2006 TABLE OF CONTENTS
at:
http://www.ispor.org/valueinhealth_index.asp
EDITORIALS
Where's the Value in Health Care?
Joel W. Hay
Substantial Returns to Health-Care Spending: But Do We Spend
Too Little or Too Much?
Martin J. Buxton
POLICY AND APPLICATION
The Return on Investment in Health Care: From 1980 to 2000
Bryan R. Luce, Josephine Mauskopf, Frank A. Sloan,
Jan Ostermann, L.
Clark Paramore
Economic Evaluation in Health Care: The Point of View of
Informed Physicians
Giovanni Fattore, Aleksandra Torbica
COMMENTARY
Bringing Health Economic Modeling to the 21st Century
David Eddy
The Future of Health Economic
Modeling: Have We Gone Too Far or Not Far Enough?
A.
Mark Fendrick
What Decision-Makers Want and What They Have Been Getting
Maurice McGregor
EMPIRICAL
Health Resource Utilization and Medical Care Cost of Acute
Care Elderly Unit Patients
Ravishankar Jayadevappa, Sumedha Chhatre, Mark Weiner, Donna
B. Raziano
Cost of Hypoglycemia in Patients with Type 2 Diabetes in Sweden
Linus Jonsson, Bjorn Bolinder, Jonas Lundkvist
Linguistic Validation of the US Spanish Work Productivity
and Activity Impairment Questionnaire, General Health Version
Mary C. Gawlicki, Margaret C. Reilly, Ana Popielnicki, Kate
Reilly
ISPOR ELEVENTH ANNUAL INTERNATIONAL MEETING
CONTRIBUTED PRESENTATION ABSTRACTS
VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS
Manuscripts for Volume 9, Issue 4 will be posted in June
2006. To view these "On-Line Early" manuscripts, simply go to
http://www.ispor.org/valueinhealth_index.asp,
log on using your membership information, and follow the link.
**NEW**
ISPOR CONNECTIONS
ISPOR CONNECTIONS: Volume 12, Issue 2, March/June 2006 is now available
to the public at:
http://www.ispor.org/news/index_new.asp.
In this issue:
·
ISPOR 2nd
Asia-Pacific Conference: Expanding, ISPOR in Asia & Beyond
·
Presidential
Fireside Chat: Postcard from Shanghai
·
ISPOR 2nd
Asia-Pacific Conference: Significance for China
·
The Value of
Society: A Critical Issue All Along the Development and Marketing of
Pharmaceuticals
2. ISPOR MEETINGS AND CONGRESSES
Top
EVIDENCE- BASED MEDICINE SYMPOSIUM
– WHAT DOES IT MEAN? HOW SHOULD REAL WORLD EVIDENCE BE USED FOR RATIONAL
DECISION MAKING? WHAT IS THE FUTURE? FREE TO ALL ATTENDEES
Co-sponsored by PhRMA Health Outcomes Committee and ISPOR
Sunday, May 21, 2006, 5:00PM-7:00PM
Philadelphia Marriott Downtown, Philadelphia, PA, USA (Prior to the ISPOR 11th Annual International Meeting)
For more
information, go to:
www.ispor.org/meetings/phila0506/symposium.asp
**UPDATES**
ISPOR 11th ANNUAL INTERNATIONAL MEETING - MAY 20-24, 2006
Philadelphia Marriott Downtown, Philadelphia, PA, USA
Please use the PERSONAL MEETING SCHEDULER to plan your days at the 11th Annual International
Meeting!
See:
ispor.confex.com/ispor/intl2006/scheduler/
ISPOR FORUMS
Monday, May 22, 2006, 4:30PM-5:30PM
http://www.ispor.org/meetings/phila0506/052206.asp#forums
What Students Should Know About Medicare Part D
Three speakers will discuss Medicare Part D from various
perspectives. The effects of the Medicare Prescription Drug Benefit on
providers, beneficiaries, and others will be presented.
International Perspectives of Pharmaceutical Risk Management
(RM)
This forum will compare and contrast RM from an international
perspective and provide an open forum for discussion of international issues
regarding RM.
Economics, Determinants, & Methods of Analysis of
Medication Compliance & Persistence
Methods for use of retrospective data to measure compliance,
a checklist for the measurement of compliance in prospective studies, and key
issues in the statistical distributions of different compliance measures.
Approaches to new methods will be described, focusing on concepts that may
improve validity and reliability will be discussed in this forum.
Real World Data: Importance, Limitations & Need for Good
Research Practices
The ISPOR Task Force on Real-World Data has prepared a draft
final report and circulated it for review and comment to a large internal ISPOR
Review Group. This forum will review key elements of the draft report, the
feedback received from the Review Group, and issues that need further
discussion.
EBM, HTA and Evidence-based Reimbursement
A new definition of evidence-based medicine (EBM), a set of
principles and methods intended to ensure that medical decisions, guidelines,
and other health care policies are based on and consistent with good evidence
of effectiveness and benefit, will be presented. The need to unify the current
definition of EBM (which focuses on health care decisions of the individual)
and this new definition of EBM (which focuses on population-based health care
decisions) are needed to solve both clinical and value issues. During this forum, EBM, health technology assessment (HTA),
and health care policy decisions (such as reimbursement decisions) will
be discussed.
Issues in Assessing Good Practice Guidelines for Budget
Impact Analyses
Task force members will present the key recommendations from
the draft task force report about the analytic framework, the inputs and data
sources, and reporting format for a budget impact analysis in this forum.
Vision 2010 Implementation Task Force Report
During this forum, the ISPOR 2010 task force will share a
first version of a new plan establishing proposed actions for ISPOR to meet the
vision 2010 objectives.
Tuesday, May 23, 2006, 4:45PM-5:45PM
http://www.ispor.org/meetings/phila0506/052306.asp#forums
ISPOR Comments on FDA Patient Reported Outcomes
Guidance
During this forum, the ISPOR PRO SIG will discuss ISPOR
comments to the draft FDA PRO Guidance, submitted April 4, 2006.
Patient
Registry Global Strategic Applications
The ISPOR Patient Registry SIG is
developing a 'white paper' on how to develop and operationalize patient
registries. Key issues in developing, operationalizing, and using a patient
registry in health outcomes will be presented during this forum.
ISPOR Medical Device & Diagnostics Outcomes Research:
Issues & Good
Research Practices
ISPOR has launched an initiative to address methodological
issues and good research practices when conducting outcomes research for medical
devices and diagnostics. The product of this initiative is a book titled: Medical
Device & Diagnostics Outcomes Research: Issues & Good Research
Practices (THE BOOK). THE BOOK will address issues related to current
health technology assessment methodologies and recommend good outcomes research
practices that are specifically "tailored" for fast-paced, medical
device and diagnostics technology environment. During this forum, THE BOOK
outline and key issues will be presented.
ISPOR SPECIAL EVENT - REGISTER NOW AND SAVE 20%
ISPOR ROCKS AT THE HARD ROCK CAFÉ featuring the musical
talents of ISPOR members. Be a part of this great networking opportunity! Don't miss out on this
one of a kind entertainment experience! Enjoy a buffet complete with appetizers,
pasta stations, dessert, and drink ticket. Groove to the sounds of the ISPOR
Bands!
Monday, May 22, 2006, 8:15-11:30PM
Hard Rock Café, Philadelphia, PA, USA
Buy your tickets early. Go to:
http://www.ispor.org/meetings/phila0506/party.asp
Early registration fee:
US$45.00; Registration fee at meeting: US$55.00
SYMPOSIA:
HANDLING ISSUES AROUND MISSING DATA IN ECONOMIC
ANALYSIS
sponsored by IMS Health
Monday, May 22, 2006, 1:00PM-2:00PM
For program, go to:
http://www.ispor.org/meetings/phila0506/052206.asp#IMS_symp
POWERFUL DATA, MEANINGFUL ANSWERS: AN
INTRODUCTION TO THE HEALTHCARE COST & UTILIZATION PROJECT (HCUP) Sponsored by the Agency for Healthcare Research and
Quality, United States Department of Health and Human Services
Tuesday, May 23, 2006, 7:00AM-8:00AM
For program, go to:
http://www.ispor.org/meetings/phila0506/052306.asp#POWERFULDATA
HEALTH CARE POLICY DEVELOPMENT USING OUTCOMES
RESEARCH Sponsored
by the Department of Health Policy, Jefferson Medical College
Tuesday, May 23, 2006, 1:00-2:00PM
For program, go to:
http://www.ispor.org/meetings/phila0506/052306.asp#POLICYDEVELOPMENT
HOTEL RESERVATIONS:
Reservation
Cancellation Policy:
A credit
card or guaranteed payment for one nights room and tax is required to reserve a
room. The revised deadline for hotel reservation cancellation is May 1, 2006,
5:00PM EDST. Cancellations after May 1, 2006 will incur a 1 room-night deposit
Online
reservations and additional information at:
http://www.ispor.org/meetings/phila0506/hotel_reservation.asp
SPONSORSHIP OPPORTUNITIES:
Sponsorship
Opportunities are available at:
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=2
PROFESSIONAL RECRUITMENT CENTER (PRAP)
Advertise employment
opportunities:
http://www.ispor.org/prap.asp
For more 11th
Annual Meeting program info, go to: http://www.ispor.org/meetings/phila0506/index.asp
*****************************************************************************************************
ISPOR 9th ANNUAL EUROPEAN CONGRESS
Radisson SAS Falconer Hotel & Conference Center
Copenhagen, Denmark • 28-31 October 2006
CALL FOR ABSTRACTS
DEADLINE: 19 JUNE 2006
To
submit your abstract now please go to:
http://ispor.confex.com/ispor/euro9/index.html
**UPDATES**
FIRST PLENARY SESSION-
Sunday,
29 October 2006, 13:30-15:00
HEALTH
TECHNOLOGY ASSESSMENT (HTA) AS A BASIS FOR REIMBURSEMENT AND PRIORITIES IN
HEALTH CARE
European
and Industry Perspective Speaker: Richard Bergström MScPharm, Managing Director, Swedish
Association of the Pharmaceutical Industry, Stockholm, Sweden
Government
and Nordic Perspective Speaker: Audun Hagaa MSc, Deputy Director General, Ministry
of Health, Oslo, Norway
For more
information go to:
http://www.ispor.org/congresses/denmark1006/102906.asp
SECOND PLENARY SESSION
Monday,
30 October 2006, 9:00-10:30
EVIDENCE
BASED MEDICINE (EBM): TIME FOR ASKING CRITICAL QUESTIONS
EBM -
Time for Asking Critical Questions?
Speaker: Ivar Sonbo Kristiansen MD, PhD,
MPH, University of Oslo, Institute of Health Management and Health Economics, Oslo, Norway
EBM -
Emerging Reality and Assorted Myths
Speaker: Paul Glasziou MD, Professor, Department of Primary
Health Care Old Road Campus, University of Oxford, Oxford, UK
For more
information go to:
http://www.ispor.org/congresses/denmark1006/103006.asp
THIRD PLENARY SESSION
Tuesday,
31 October 2006, 9:00-10:30
SOCIETAL
VALUE OF A QALY
Looking
for Willingness to Pay (WTP) Threshold for a QALY-- Does it make sense? -- A
Critical View
Speaker: Dorte Gyrd-Hansen PhD, Professor, University of Southern Denmark, Institute of Public Health, Odense, Denmark
Looking
for Willingness to Pay (WTP) Threshold for a QALY -- Does it make sense? -- A
Practical View
Speaker: Martin Buxton BA Soc Sci, Professor, Brunel University Health
Economics Research Group, Uxbridge, Middlesex, UK
For more
information go to :
http://www.ispor.org/congresses/denmark1006/103106.asp
EXHIBIT OPPORTUNITIES
Register
now for Exhibit space:
https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=3
SPONSORSHIP OPPORTUNITIES
Register
for sponsorship promotional opportunities:
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=3
For more 9th Annual European Congress program info, go to:
http://www.ispor.org/congresses/denmark1006/index.asp
3. EDUCATION ACTIVITIES
Top
ISPOR SHORT COURSES–PRIOR TO ISPOR 11TH
ANNUAL INTERNATIONAL MEETING - May 2006
Twenty-one short courses including 9 NEW courses will be given this year, with 8 courses on
Saturday, May 20, 2006, and 13 courses
on Sunday, May 21, 2006.
SATURDAY, MAY 20, 2006
**NEW**
Qualitative Methods for Quality of
Life/Patient-Reported Outcomes
Faculty: Carol Tishelman PhD, RN, Professor,
Karolinska Institutet and R& D unit Foundation Stockholms Sjukhem, Stockholm Sweden
For full descriptions of ALL Saturday short courses,
please visit:
http://www.ispor.org/meetings/phila0506/sc_sat.asp
SUNDAY, MAY 21, 2006
**NEW**
Cost-Effectiveness Analysis alongside Clinical
Trials
Faculty: Scott Ramsey MD, PhD, Full Member, Fred
Hutchinson Cancer Research Center, Seattle, WA, USA; Richard Willke PhD,
Senior Director, Group Leader, Global Outcome Research, Worldwide Outcomes
Research, US Development Sites Pfizer, Inc., Bridgewater, NJ, USA
**NEW**
Use of Real World Data in Outcomes Research
Faculty: Diana Brixner PhD, RPh, Associate Professor
and Department Chair, College of Pharmacy, University of Utah, Salt Lake City,
UT, USA; Gregory de Lissovoy, PHD, MPH Senior Research Scientist, Health
Analytics Group, United BioSource Corp., Bethesda MD; Daniel M. Huse MA,
Practice Leader, Information Products, Thomson Medstat Inc., Cambridge, MA, USA
**NEW**
Bayesian Analysis: Advanced
Faculty: Bryan Luce MBA, PhD, Senior Vice
President, Science Policy, United BioSource Corporation, Bethesda, MD, USA; Christopher
S. Hollenbeak PhD, Surgery and Health Evaluation Sciences, Penn State
College of Medicine, Hershey, PA, USA; David Vanness PhD, Assistant
Professor of Population Health Sciences, University of Wisconsin Medical
School, Madison, WI, USA; Keith R Abrams MSc, Professor of Medical
Statistics & Course Director, Centre for Biostatistics & Genetic
Epidemiology, Department of Health Sciences, University of Leicester,
Leicester, UK
**NEW**
Propensity Scores and Comorbidity Risk Adjustment
Faculty: Fadia Shaya MPH, PhD, Assistant Professor/Associate
Director, University of Maryland School of Pharmacy, Center on Drugs and Public
Policy, Baltimore, MD, USA
**NEW**
Patient Registries: Overview & Application
Faculty: Jeff Trotter MBA, President, Ovation Research Group,
Highland Park, IL, USA
**NEW**
Outcomes Research for Medical Devices &
Diagnostics
Faculty: Seema Sonnad PhD, Associate Professor, Department of Surgery, University
of Pennsylvania, Philadelphia, PA, USA; Stacey Ackerman, MSE, PhD,
Vice President,
Covance Market Access Services, San Diego, CA, USA
**NEW**
Case Studies in Pharmaceutical/Biotech Pricing II
– Advanced
Faculty: Jack Mycka, President, Optimar Strategic Consulting
LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector
(Value Added Business Strategies), Milan, Italy
**NEW**
Risk Assessment: Analysis and Management
Faculty: Dennis Raisch PhD, Associate Center Director,
Scientific Affairs, VA Cooperative Studies Program, Clinical Research Pharmacy,
Albuquerque, NM, USA; Anthony Lockett MD, PhD, MBA, Medical
Director, ICO, Leeds, UK; Suellen Curkendall PhD, Principal Investigator,
Cerner Health Insights, Vienna, VA, USA
**PLEASE NOTE** There has been a change to the
short course, Advanced Quantitative Methods for Quality of Life /
Patient-Reported Outcomes. Please contact
jharvey@ispor.org
if you have any questions related to the following:
Course Description: This course will provide an in-depth discussion of
operating characteristics, validity testing, analysis and interpretation with
examples of each. It will provide a range of methods that may help to solve
common problems encountered with quality of life / patient-reported
outcomes. These include an overview of psychometric validation methods
including: a brief overview of Rasch analysis, pragmatic issues in validating a
PRO from clinical trial data, ePRO validation, methods of estimation of
minimally clinically important differences and alternatives to provide
information on interpretation Clinical trial analysis will include missing
data analysis techniques and mixed modelling appropriate to PRO data and study
design, There will be a focus on addressing these issues within the
framework provided by the PRO guidance recently released by the SEALD group at
the FDA. Specific examples will be used throughout the course and participants
will be asked to complete a short exercise. This course is designed for
those with intermediate experience in health-related quality-of-life
assessment.
For full descriptions of ALL Sunday short courses, please
visit:
http://www.ispor.org/meetings/phila0506/sc_sun.asp
4. STUDENT NEWS
Top
**NEW**
Student
activities at the ISPOR 11th Annual International Meeting include:
ISPOR
Student Leadership Retreat (invitation only)
Sunday, May
21, 2006, 10:00AM-4:00PM
ISPOR
Student Council Dinner (invitation only)
Sunday, May
21, 2006, 5:00PM-6:30PM
ISPOR
Icebreaker Reception
Sunday, May
21, 2006, 7:30PM-9:00PM
ISPOR
Mock Interview Session
Monday, May
22, 2006, 2:00PM-4:00PM
ISPOR
Student Forum
What Students Should Know About Medicare Part D
International Perspectives Regarding Pharmaceutical Risk Management
The Economics, Determinants, & Methods of Analysis of
Medication Compliance & Persistence
Monday, May
22, 2006, 4:30-5:30PM
Student
Roundtable Discussions at the 11th Annual International Meeting
Tuesday,
May 23, 2006, 7:00AM-8:00AM
For
more details on the ISPOR Student Network, please visit:
http://www.ispor.org/student/student_index.asp
5. ISPOR SPECIAL INTEREST GROUPS (SIG)
Top
SPECIAL
INTEREST GROUPS are
very important to ISPOR to achieve its mission. Their goals are to: develop
consensus; stimulate debate; advance knowledge/understanding; publish good
research practices; develop indices & tools for researchers and
decision-makers; compile health care information for public; respond to health
care public policy.
RISK
MANAGEMENT SIG
**NEW**
The Risk Management Special Interest Group will present a
NEW short course at the ISPOR 11th Annual International Meeting, entitled “Risk
Assessment: Analysis and Management”.
Additionally, they will present their analysis of the ISPOR
Membership Survey on Risk Perception in a forum
at the ISPOR 11th Annual International Meeting, entitled,
“International Perspectives Regarding Pharmaceutical Risk Management,” Monday,
May 22, 2006, 4:30PM. The discussion will include a lively debate on
international regulatory issues surrounding risk management.
**NEW**
HEALTH TECHNOLOGY ASSESSMENT IN EVIDENCE-BASED REIMBURSEMENT SIG
The ISPOR Value-based Reimbursement SIG and Health
Technology Assessment SIG have been combined into a new SIG entitled: Health
Technology Assessment in Evidence-based Reimbursement. The new combined
Working Groups are:
Health Technology Assessment and
Good Research Practices for Reimbursement Decisions Working Group
Global Reimbursement Requirements Working Group
Global Health Technology Assessments
Used in Health Care Reimbursement Working Group
Health Technology Assessment of
Emerging New Technologies Working Group
**NEW**
PATIENT
REPORTED OUTCOMES SIG
ISPOR Comments on FDA PRO Guidance will be discussed at the
ISPOR PRO SIG Forum. Please attend the Forum on TUESDAY, MAY 23, at 4:45PM -
5:45PM SALON A-LEVEL 5
**NEW**
MEDICATION COMPLIANCE & PERSISTENCE SIG
11th Annual International Meeting
Activities
Members of the Medication Compliance & Persistence SIG
will be presenting two workshops:
Monday, May 22nd 2:00-3:00PM
METHODS FOR MEDICATION COMPLIANCE STUDIES: PATIENT
COMPLIANCE AS A PREDICTOR OF CLINICAL AND ECONOMIC OUTCOMES
Discussion Leaders: Joyce Cramer Associate
Research Scientist, Yale University School of Medicine, West Haven, CT, USA, Femida
Gwadry-Sridhar PhD, Assistant Professor, University of Western Ontario, and
London Health Sciences Centre, London, ON, Canada; Joshua S. Benner PharmD,
ScD, Principal, ValueMedics Research, LLC, Falls Church, VA, USA
Tuesday, May 23rd 2:15-3:15PM
AN ECONOMIC FRAMEWORK TO UNDERSTAND MEDICATION COMPLIANCE
AND PERSISTENCE
Discussion Leaders: Judith Shinogle PhD, Senior Economist, RTI,
International, Washington, DC, USA; Pamela Peele PhD, VP, Health
Economics, UPMC Health Plan, Pittsburgh, PA, USA; Rachel Elliot PhD,
Clinical Senior Lecturer, The University of Manchester, Manchester, UK
For further information about the work of this group please
attend the forum on Monday, May 22nd at 4:30PM – 5:30PM
THE ECONOMICS, DETERMINANTS, & METHODS OF ANALYSIS OF
MEDICATION COMPLIANCE & PERSISTENCE: ISPOR Medication Compliance &
Persistence SIG Forum
Moderator: Joyce Cramer BS, Medication Compliance & Persistence SIG Chair &
Associate Research Scientist, Yale University School of Medicine, West Haven,
CT, USA
Topic: Methods for Analysis of Compliance and Persistence
The status of the recommended approaches for conducting
and/or reviewing
both retrospective and prospective compliance and persistence studies
will be discussed.
Speaker: Andrew Peterson, PharmD, Analyses Standards Leadership Group
& Assistant Professor, University of the Sciences in Philadelphia, Philadelphia , PA, USA
Topic: Determinants Of Medication Compliance And Persistence
The literature on interventions that have been used to
improve compliance has been missing a theoretical framework or hypothesis
detailing an expected effect of the intervention on compliance. Examples of
frameworks include individual level, interpersonal level and community level
factors that may have either a direct effect on compliance or act as a
mediator. Models can be developed for researchers developing prospective
studies to consider relevant constructs in the development and delivery of
interventions to improve compliance.
Speaker: Femida Gwadry-Sridhar PhD, RPh, MSc, BSc Phm, Determinants of Compliance &
Persistence Working Group Chair & Associate Director Critical Care Research
Network and Assistant Professor, Department of Medicine, University of Western
Ontario, ON, Canada
Topic: Economics of Compliance & Persistence
Economic models of behavior can be related to
medication-taking behaviors. Models include: a) derivations of
Neumann-Morgenstern utility theory to explain decisions under uncertainty about
present and future health production and consumption; b) the quantification by
patients of those utilities using stated preference methods; c) bilateral
bargaining models to explore patient provider interactions; d) prospect theory
models to examine how choices vary depending on the reference point (i.e.,
original health state) when faced with risk or uncertainty; and e) issues
related to time preferences and discount rates.
Speaker: Judith Shinogle PhD, MSc, Economics of Compliance and
Persistence Leadership Group & Senior Economist, RTI International,
Washington, DC, USA
**NEW**
PATIENT REGISTRY SIG
PATIENT REGISTRY GLOBAL STRATEGIC
APPLICATIONS FORUM
Tuesday, May 23, 2006 4:45PN-5:45PM
The Strategic Applications for Patient Registries SIG has
focused on consolidating our scope of activities by 1) integrating the US and
Global SIGS into one group because of similar interests expressed by teams, and
2) preparing a White Paper to inform how best to develop and operationalize the
use of patient registries. The team has successfully integrated the
functions and has had several meetings to discuss key issues regarding how
registries are utilized in health outcomes and in the Pharmaceutical industry.
We have approved the core outline for a White Paper, which can serve as a
policy guidance document for ISPOR.
For more
information and to join an ISPOR SIG, go to
http://www.ispor.org/sigs/sigsindex.asp.
The ISPOR SIGs are:
HEALTH TECHNOLOGY ASSESSMENT IN EVIDENCE-BASED REIMBURSEMENT
SIG
TRANSLATING RESEARCH TO PRACTICE SIG
PATIENT REGISTRY SIG
PATIENT
REPORTED OUTCOMES SIG
MEDICATION COMPLIANCE & PERSISTENCE SIG
RETROSPECTIVE DATABASE SIG
6. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES
Top
TASK FORCE ACTIVITIES
BUDGET IMPACT ANALYSIS TASK FORCE
The Task
Force held an intensive face-to-face meeting in March where all details in the
Task Force Report were finalized. Pending review, the Task Force will present
their Good Practices Report for publication this summer.
They will be
presenting the report process, themes and projections during a forum at the ISPOR
11th Annual International Meeting, entitled, “Issues in Assessing
Good Practice Guidelines for Budget Impact Analyses,” on Monday, May 22, 2006,
4:30PM.
7. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS
Top
LOCAL CHAPTER NEWS
For more
details on ISPOR Local Chapters, go to:
www.ispor.org/local_chapters/index.asp
ISPOR ASIA CONSORTIUM
For more
details on this consortium, please visit:
http://www.ispor.org/consortiums/asia.asp
8. EMPLOYMENT
Top
OVER 50 POSITIONS LISTED AT THE ISPOR WEBSITE:
http://www.ispor.org/employment/employment_index.asp
Advertise
your positions on ISPOR Website (~1 million hits per month)
INTERNSHIPS
Visit
ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP)
at
http://www.ispor.org/iprap/index.asp
STUDENTS: Post your CVs/resumes for employers to view and search for
internship positions available. Nine student resumes posted!
EMPLOYERS: Post
your Intern positions for FREE and access CVs/resumes from students. If
you have any questions, please contact:
iprap@ispor.org. For more information, visit
our website at
http://www.ispor.org/prap.asp
9. ISPOR MEMBERSHIP
Top
Update your
email address at
https://www.ispor.org/members/addresschange.asp!
Your email address is required as part of your log in information in the
members only section of the ISPOR website.
| 
